ACCESS TO PAIN MEDICATION QUESTIONNAIRE 2011, RESOLUTION 53/4

Similar documents
Access to pain therapy in the UN resolutions: worldwide perspective

Questionnaire for National Competent Authorities on the availability of Internationally Controlled Substances for medical and scientific purposes

C. Impediments to the availability of narcotic drugs

Gilberto Gerra. Drug Prevention and Health Branch

International Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

UNODC/HONLAF/26/CRP.1

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

SNo Quarter 2 National Survey on Drug Abuse: 21 The extent and patterns of drug abuse in India have been changing The Board appreciates the decision b

HIV MANAGEMENT PROGRAMME APPLICATION FORM

Guideline for the Rational Use of Controlled Drugs

European Legal Database on Drugs

Ontario s Narcotics Strategy

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and

SUPPLY OF OPIATE RAW MATERIALS AND DEMAND FOR OPIATES FOR MEDICAL AND SCIENTIFIC PURPOSES

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good

Challenges in Access to controlled medicines

ADOPTED BY THE GENERAL ASSEMBLY, THE ECONOMIC AND SOCIAL COUNCIL (ECOSOC) AND THE COMMISSION ON NARCOTIC DRUGS (CND).

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS

Requirements of the International Drug Control Conventions, Catherine Muganga Legal Officer, UNODC Feb 2015

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY

MEDICINES REGULATORY AUTHORITIES: CURRENT STATUS AND THE WAY FORWARD. Report of the Regional Director EXECUTIVE SUMMARY

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

International Narcotics Control Board. United Nations Convention against Illicit Traffic In Narcotic Drugs and Psychotropic Substances of 1988

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

Section I. Short-acting opioid Prior Authorization Criteria

POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

WHO/EDM/QSM/ ENGLISH ONLY DISTRIBUTION: GENERAL WORLD HEALTH ORGANIZATION

REPORTING INSTRUMENT

WHAT YOU NEED TO KNOW TO ABOUT AB 474

RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA. 11 October 2002 No: 68 Ulaanbaatar. Adoption of the Government Policy on Drugs

REPORTING INSTRUMENT

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Nicaragua. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

- Description, Objectives, Operational Framework

International drug control conventions promote better health

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 December 2007

REPORTING INSTRUMENT. Vietnam

For personal use only

Launch of the INCB Annual Reports 2015

Unit title: Legal and Social Responsibilities of a Personal Licence Holder

Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Law of the Republic of Azerbaijan on the Control of Illicit Trafficking in Narcotic Drugs, Psychotropic Substances and Precursors

Prescribing and Dispensing Drugs

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and

Industrial Hemp. What is industrial hemp? Is industrial hemp the same as marihuana? Why has hemp been illegal to cultivate in Canada in the past?

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

Ref: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State

ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) ( ) IMPLEMENTATION MATRIX

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

REPORTING INSTRUMENT

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

I. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY

AN OPTIMAL REGULATORY MIX FOR METHAMPHETAMINE PRECURSORS?

SOUTH DAKOTA BOARD OF REGENTS. Policy Manual

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)

Colorado State Board of Medical Examiners Policy

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

Recent trends in medical cannabis use in Canada

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary

Crowe Healthcare Webinar Series

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

Article 18. 5) Act No. 108/2000, Article 1. 6) Act No. 83/2004, Article 1. 7) Act No. 167/2007, Article 74.

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

World Drug Report 2017

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.

QUESTIONNAIRE ANTI MONEY LAUNDERING (Including Counter Terrorist Financing, Financial Sanctions Monitoring, KYC)

Changing practice to support service delivery

4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016

Interstate dispensing : A case for uniform, intuitive legislation

2017 Legislative Policy Update

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

REPORTING INSTRUMENT

Quality, Safety and Sourcing in Unlicensed Medicines

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Prescription Drug Abuse National Perspective

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

About this consent form

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

Strategies for Federal Agencies

DRUG-FREE UNIVERSITY COMMUNITY AND WORKPLACE

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Review of Controlled Drugs and Substances Act

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.18

OICS INCB. Statement by Dr. Viroj Sumyai, President, International Narcotics Control Board (INCB)

Michigan Legislative and Regulatory Pharmacy Initiatives Update

Regulations for the prescribing of Schedule 8 medicines in WA

See Important Reminder at the end of this policy for important regulatory and legal information.

SACI ALCOHOL AND DRUG ABUSE PREVENTION POLICY

Medicare Advantage Outreach and Education Bulletin

Transcription:

ACCESS TO PAIN MEDICATION QUESTIONNAIRE 2011, RESOLUTION 53/4 Promoting adequate availability of internationally controlled licit drugs for medical and scientific purposes while preventing their diversion and abuse Country or territory Date Competent office Name of officer responsible Title or function: Contact addresses, Tel.: Fax: Email: Signature:

Part A 1. What was the forecasted estimated quantity of Opioids Analgesics (Synthetic and Non Synthetic) to be consumed for domestic medical and scientific purposes as reported to INCB for the latest year Synthetic Opioids Non- Synthetic Opioids (Kgs*) (Kgs*) *Please round up to the closest number, if not available report as NA 2. Did your forecast match the need Opioids (Synthetic and Non Synthetic) at the end of the year It was correct It was an overestimate It was an underestimate 3. What are your estimates above based on? ( please tick what is applicable) Size of population in need of medicine Yes No Number of hospital beds Yes No Morbidity data Yes No Request of manufacturers/importers Yes No Information from medical associations Yes No Past consumption patterns Yes No Other(please specify) Yes No 4. Is there a national record of patients receiving for monitoring purposes? Yes No 5. If yes, please specify number of patients on record patients

Part B 6. What is the lead agency for the control of illicit activities related to in your country? Please Specify Please select the appropriate response as per the latest information in your country Agree Disagree Don t know 7. There are designated departments authorised to stock 8. National laws/regulations governing the distribution, prescription or dispensing of exist 9. National policies or guidelines for the availability of for medical pruposes exist 10. A special governmental license is needed to prescribe 11. A special governmental license is needed to manufacture 12. A special governmental license is needed to import/trade 13. A special license is needed to dispense Opioid Analgesics 14. A system is in place for the inspection of authorized persons and enterprises responsible for: a. prescription of b. dispensing prescription of c. stocking/storage of 15. A government regulated policy prohibiting the advertisement of to the general public exists 16. All in the local market are adequately labelled 17. Only Medical Doctors can prescribe Opioid Analgesics 18. There are training courses available to Medical Doctors about the use and prescription of Opioid Analgesics for pain management * *If Agree, specify the type of training (otherwise skip to q19) select all that apply a) Professional training (part of general medical training curriculum) b) Specialized training (part of medical specialty training) c) On the job or on site training d) Part of a continuous education programme

Part C 19. There are special or multiple prescription forms as a requirement for the dispensing of? Yes No 20. Are all Medical Doctors entitled to prescribe? Yes No 21. Do patients receive special permission or registration from a specialised department to render them eligible to receive? *(Specify which patients ) 22. Is there a restriction on the average number of days supply that may be provided in a single prescription? * (Specify number of days ) 23. Is there a limitation on the doses prescribed in a single prescription? * (Specify number dose mgs) 24. Are there designated pharmacies with licence to dispensing? Yes * No, all are authorized No, dispensing is not through pharmacies ** * (Specify number of pharmacies ) ** (Specify dispensing locality ) 25. Who covers the costs for prescribed Narcotic drugs or (select all that apply)? a) The government 100% b) The government partially c) Third party (Insurance) 100% d) Third part (Insurance)partially e) Patients, out of pocket 100% f) Patients, out of pocket partially 26. Does the government has a yearly budget allotted for the purchase of Opioid Analgesics? * (Specify yearly budget Approximate US$ equivalent)

27. Are sanctions or penalties in place for the mishandling of prescriptions in the following cases? NO YES Severe Mishandling by patients due to drug dependence Unintentional mishandling or prescription of Unauthorised dispensing of Unauthorised distribution of Trafficking of controlled substances Dispensing without prescription Part D Please select the appropriate response as per the latest information in your country Agree Somewhat Somewhat Agree Disagree 28. There is sufficient import or manufacture of to meet the national demand 29. National policies are an impediment to the availability of medical 30. There is an administrative burden of the regulatory requirements for 31. There is a reluctance to stock because of concerns about legal sanctions at the national level 32. There is sufficient training of Medical Doctors about prescribing 33. Medical Doctors are reluctant to prescribe due to concerns of legal sanctions 34. Medical Doctors are reluctant to prescribe due to concerns about addiction or abuse 35. Family and social values stigmatize the use of 36. The cost of is an access barrier to patients in need 37. The cost of is an impediment for government to subsidise the patients in need Yes NOT Severe Disagree Don t know